Suchergebnisse - "Perrone, Francesco"

PubPharm (24)

1

Machine Learning Application Identifies Germline Markers of Hypertension in Patients With Ovarian Cancer Treated With Carboplatin, Taxane, and Bevacizumab

enthalten in: Clinical pharmacology and therapeutics | 2023

von Polano, M. | Bedon, L. | Dal Bo, M. | +19

2

Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3) : a multicentre, open-label, randomised, controlled, phase 2 trial

enthalten in: The Lancet. Oncology | 2023

von Pignata, S. | Scambia, G. | Schettino, C. | +128

CommentIn: Lancet Oncol. 2023 Mar;24(3):201-203. - PMID 37052963

3

Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients : the phase IV MITO-16A/MaNGO-OV2A study

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2021

von Daniele, G. | Raspagliesi, F. | Scambia, G. | +30

4

Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer : a randomised, phase 3 trial

enthalten in: The Lancet. Oncology | 2021

von Pignata, S. | Lorusso, D. | Joly, F. | +62

5

Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

enthalten in: Gynecologic oncology | 2019

von Daniele, G. | Arenare, L. | Scambia, G. | +25

6

The MITO CERV-2 trial : A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer

enthalten in: Gynecologic oncology | 2019

von Pignata, S. | Scambia, G. | Lorusso, D. | +29

7

Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer : The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2017

von Pignata, S. | Scambia, G. | Bologna, A. | +25

8

Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB) : A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trial

enthalten in: Gynecologic oncology | 2017

von Daniele, G. | Lorusso, D. | Scambia, G. | +20

9

Correlation of Serum Cystatin C with Glomerular Filtration Rate in Patients Receiving Platinum-Based Chemotherapy

enthalten in: Analytical cellular pathology (Amsterdam) | 2016

von Cavalcanti, E. | Barchiesi, V. | Cerasuolo, D. | +8

10

Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer : a systematic review and meta-analysis of individual patient data

enthalten in: The Lancet. Oncology | 2014

von Rossi, A. | Chiodini, P. | Sun, J. | +11

CommentIn: Lancet Oncol. 2014 Oct;15(11):1187-8. - PMID 25232000